Among them, fibronectin 1 (FN1), a marker of vascular injury previously reported to be elevated in preeclamptic patients (Wu et al., 2021), and lactate dehydrogenase A (LDHA), whose serum levels have been suggested as a marker of preeclampsia and disease severity (Nasir et al., 2025). This evidence concerns the gene LDHA and preeclampsia.